SECTION 8-ACCEPTED
accepted
on 17 Sep 2023
Last Applicant/ Owned by
Laxmi Towers
Mumbai
IN
400051
Serial Number
86005858 filed on 09th Jul 2013
Registration Number
5195859 registered on 02th May 2017
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
BLISOVI
Pharmaceuticals, namely, contraceptives; oral contraceptives; oral hormonal contraceptives; contraceptive preparations and substances; hormone replacement therapies; hormonal agents for treating disorders and conditions related to women's health, namely, symptoms and conditions associated with menopause, pre-menstruation syndrome and other symptoms and conditions associated with menstruation
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceuticals, namely, contraceptives; oral contraceptives; oral hormonal contraceptives; contraceptive preparations and substances; hormone replacement therapies; hormonal agents for treating disorders and conditions related to women's health, namely, symptoms and conditions associated with menopause, pre-menstruation syndrome and other symptoms and conditions associated with menstruation
First Use Date in General
14th Jan 2016
First Use Date in Commerce
14th Jan 2016
Mark Details
Serial Number
No 86005858
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 390.51 (US-2
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 17th Sep 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 17th Sep 2023 | REGISTERED - SEC. 8 (6-YR) ACCEPTED |
| 17th Sep 2023 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED |
| 28th Apr 2023 | TEAS SECTION 8 RECEIVED |
| 02th May 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 02th May 2017 | REGISTERED-PRINCIPAL REGISTER |
| 28th Mar 2017 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 27th Mar 2017 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 24th Mar 2017 | STATEMENT OF USE PROCESSING COMPLETE |
| 21st Mar 2017 | TEAS STATEMENT OF USE RECEIVED |